1. Home
  2. GATX vs ALKS Comparison

GATX vs ALKS Comparison

Compare GATX & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GATX Corporation

GATX

GATX Corporation

HOLD

Current Price

$192.06

Market Cap

6.2B

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$33.16

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GATX
ALKS
Founded
1898
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
5.7B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
GATX
ALKS
Price
$192.06
$33.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
13
Target Price
$205.00
$42.85
AVG Volume (30 Days)
205.6K
2.0M
Earning Date
02-19-2026
02-25-2026
Dividend Yield
1.27%
N/A
EPS Growth
14.17
2.44
EPS
8.56
2.02
Revenue
$1,704,900,000.00
$1,521,338,000.00
Revenue This Year
$11.70
N/A
Revenue Next Year
$37.38
$23.22
P/E Ratio
$22.44
$16.48
Revenue Growth
10.66
1.08
52 Week Low
$139.44
$25.17
52 Week High
$192.88
$36.45

Technical Indicators

Market Signals
Indicator
GATX
ALKS
Relative Strength Index (RSI) 75.75 51.65
Support Level $188.11 $33.04
Resistance Level $192.88 $35.34
Average True Range (ATR) 3.17 1.08
MACD 0.29 -0.24
Stochastic Oscillator 94.61 23.51

Price Performance

Historical Comparison
GATX
ALKS

About GATX GATX Corporation

GATX Corp is a provider of railcar leasing and maintenance services. GATX operates in business segments including rail North America, rail international, Engine Leasing, and others. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: